MedPath

Effect of Mahanimba in Tamaka-shwasa(Bronchial Asthma)

Phase 3
Conditions
Health Condition 1: J452- Mild intermittent asthma
Registration Number
CTRI/2024/07/070153
Lead Sponsor
Post Graduate institute of Ayurveda DSSRAU Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients between the age group of 18 to 40 years of either sex present with clinical

features of Tamaka Shwasa.

2. Mild persistent cases of Asthma of duration more than 6 months (as per WHO GINA

guideline)

3. Recurrent episodes of Wheezing, Breathlessness, and Coughing particularly at night or in the morning.

Exclusion Criteria

1. Patients below 18 years and above 40 years.

2. Tuberculosis (Pulmonary).

3. Chronic obstructive pulmonary disease(COPD).

4. Pleural effusion & Emphysema.

5. Patient who need Salbutamol inhaler daily.

6. HIV positive cases.

7. Patients suffering from systemic disorders like renal failure, hypertension,

Diabetes Mellitus etc.

8. Pregnancy and lactating mother.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath